FN2 Earnings Intelligence
Cardinal Health, Inc. balance sheet (quarterly)
Cardinal Health, Inc. (CAH) Balance Sheet (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,810 | $3,326 | $4,593 | $2,777 | $3,937 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $55,264 | $54,878 | $64,009 | $65,627 | $60,940 | $65,153 | $68,587.9 |
| % Growth | - | - | - | - | - | - | 7.2% |
| Gross Profit | $1,941 | $2,123 | $2,319 | $2,397 | $2,498 | - | - |
| % Margin | 3.5% | 3.9% | 3.6% | 3.7% | 4.1% | - | - |
| EBITDA | - | - | $901 | $941 | $757 | - | - |
| % Margin | - | - | 1.4% | 1.4% | 1.2% | - | - |
| Net Income | $400 | $506 | $450 | $467 | $399 | - | - |
| % Margin | 0.7% | 0.9% | 0.7% | 0.7% | 0.7% | - | - |
| Diluted EPS | - | - | $1.88 | - | - | $2.42 | $2.88 |
| % Growth | - | - | - | - | - | - | 53.4% |
| Operating Cash Flow | - | - | $973 | - | - | - | - |
| CapEx | - | - | $108 | - | - | - | - |
| Free Cash Flow | - | - | $865 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $55,264 | $54,878 | $64,009 | $65,627 | $60,940 | $65,153 | $68,587.9 |
| Gross Profit | $1,941 | $2,123 | $2,319 | $2,397 | $2,498 | - | - |
| EBITDA | - | - | $901 | $941 | $757 | - | - |
| Net Income | $400 | $506 | $450 | $467 | $399 | - | - |
| Diluted EPS | - | - | $1.88 | - | - | $2.42 | $2.88 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,810 | $3,326 | $4,593 | $2,777 | $3,937 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $973 | - | - |
| Capital Expenditure | - | - | $108 | - | - |
| Free Cash Flow | - | - | $865 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 3.5% | 3.9% | 3.6% | 3.7% | 4.1% |
| EBITDA Margin | - | - | 1.4% | 1.4% | 1.2% |
| Net Margin | 0.7% | 0.9% | 0.7% | 0.7% | 0.7% |
| FCF Margin | - | - | 1.4% | - | - |
| Diluted EPS Growth | - | - | - | - | - |